Incidence of end-stage renal disease and risk factors for progression of renal dysfunction in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry

被引:8
|
作者
Iwase, Masanori [1 ,2 ,3 ]
Ide, Hitoshi [1 ,2 ,3 ]
Ohkuma, Toshiaki [1 ]
Fujii, Hiroki [1 ]
Komorita, Yuji [1 ]
Yoshinari, Masahito [1 ]
Oku, Yutaro [1 ]
Higashi, Taiki [1 ]
Nakamura, Udai [1 ,4 ]
Kitazono, Takanari [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan
[2] Hakujyuji Hosp, Diabet Ctr, Fukuoka, Japan
[3] Hakujyuji Hosp, Clin Res Ctr, Fukuoka, Japan
[4] Steel Mem Yawata Hosp, Diabet Ctr, Kitakyushu, Fukuoka, Japan
基金
日本学术振兴会;
关键词
Depression; Diabetic kidney disease; Dietary fiber; Lifestyle; Physical activity; Prospective study; CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; CARDIOVASCULAR EVENTS; CKD; INSUFFICIENCY; ALBUMINURIA;
D O I
10.1007/s10157-021-02136-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Epidemiological data regarding diabetic kidney disease are accumulated insufficiently in Japan. We prospectively investigated the incidence of end-stage renal disease (ESRD) and risk factors for progression of renal dysfunction in Japanese patients with type 2 diabetes. Methods 4904 participants with type 2 diabetes (mean age 65 years, mean estimated glomerular filtration rate (eGFR) 75 mL/min/1.73 m(2), proportion of eGFR < 60 mL/min/1.73 m(2) 21%) were investigated for the progression to ESRD requiring dialysis in multicenter outpatients registry for 5 years. Risk factors for progression of renal dysfunction (>= 30% decline in eGFR from the baseline and annual eGFR decline rates) were evaluated. Results The incidence rates of ESRD and all-cause mortality were 4.1/1000 person-years and 12.3/1000 person-years, respectively, and increased according to stages of chronic kidney disease (eGFR < 30 mL/min/1.73 m(2), incidence of ESRD 176.6/1000 person-years, all-cause mortality 57.4/1000 person-years). Incidence of >= 30% decline in eGFR from the baseline was 16.4% at 5 years, and the mean annual decline rate was -1.84 mL/min/1.73 m(2)/year. The progression of renal dysfunction was significantly associated with older age, poor glycemic control, blood pressure, albuminuria, eGFR, previous cardiovascular disease, lifestyle factors (body mass index, reduced intake of dietary fiber, increased intake of sodium, no regular exercise), and depressive symptoms. Conclusions This prospective study has emphasized the importance of multifactorial interventions on risk factors to suppress the high incidence of ESRD in Japanese patients with type 2 diabetes.
引用
收藏
页码:122 / 131
页数:10
相关论文
共 50 条
  • [21] Development and validation of a risk prediction model for end-stage renal disease in patients with type 2 diabetes
    Lin, Cheng-Chieh
    Li, Chia-Ing
    Liu, Chiu-Shong
    Lin, Wen-Yuan
    Lin, Chih-Hsueh
    Yang, Sing-Yu
    Li, Tsai-Chung
    SCIENTIFIC REPORTS, 2017, 7
  • [22] The impact of losartan on the lifetime incidence of end-stage renal disease and costs in patients with type 2 diabetes and nephropathy
    Carides, George W.
    Shahinfar, Shahnaz
    Dasbach, Erik J.
    Keane, William F.
    Gerth, William C.
    Alexander, Charles M.
    Herman, William H.
    Brenner, Barry M.
    PHARMACOECONOMICS, 2006, 24 (06) : 549 - 558
  • [23] The Impact of Losartan on the Lifetime Incidence of End-Stage Renal Disease and Costs in Patients with Type 2 Diabetes and Nephropathy
    George W. Carides
    Shahnaz Shahinfar
    Erik J. Dasbach
    William F. Keane
    William C. Gerth
    Charles M. Alexander
    William H. Herman
    Barry M. Brenner
    PharmacoEconomics, 2006, 24 : 549 - 558
  • [24] Risk factors for progression of renal disease in patients with type 2 diabetes.
    Isreb, MA
    Daoud, TM
    Chatha, MP
    Leehey, DJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 685A - 686A
  • [25] Modified end-stage renal disease risk score for Chinese type 2 diabetic patients-the Hong Kong Diabetes Registry
    Yang, X. L.
    So, W. Y.
    Kong, A. P. S.
    Ho, C. S.
    Lam, C. W. K.
    Ng, M. H. L.
    Lyu, R. R.
    Yin, D. D.
    Chow, C. C.
    Cockram, C. S.
    Tong, P. C. Y.
    Chan, J. C. N.
    DIABETOLOGIA, 2007, 50 (06) : 1348 - 1350
  • [26] Diabetes increases risk of end-stage renal disease in SLE
    McHugh, Jessica
    NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (04) : 193 - 193
  • [27] Diabetes increases risk of end-stage renal disease in SLE
    Jessica McHugh
    Nature Reviews Rheumatology, 2023, 19 : 193 - 193
  • [28] Circulating proteins protect against renal decline and progression to end-stage renal disease in patients with diabetes
    Dom, Zaipul I. Md
    Satake, Eiichiro
    Skupien, Jan
    Krolewski, Bozena
    O'Neil, Kristina
    Willency, Jill A.
    Dillon, Simon T.
    Wilson, Jonathan M.
    Kobayashi, Hiroki
    Ihara, Katsuhito
    Libermann, Towia A.
    Pragnell, Marlon
    Duffin, Kevin L.
    Krolewski, Andrzej S.
    SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (600)
  • [29] Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study
    Niewczas, Monika A.
    Sirich, Tammy L.
    Mathew, Anna V.
    Skupien, Jan
    Mohney, Robert P.
    Warram, James H.
    Smiles, Adam
    Huang, Xiaoping
    Walker, Walker
    Byun, Jaeman
    Karoly, Edward D.
    Kensicki, Elizabeth M.
    Berry, Gerard T.
    Bonventre, Joseph V.
    Pennathur, Subramaniam
    Meyer, Timothy W.
    Krolewski, Andrzej S.
    KIDNEY INTERNATIONAL, 2014, 85 (05) : 1214 - 1224
  • [30] The effect of diabetes on incidence and mortality in end-stage renal disease in Germany
    Hoffmann, Falk
    Haastert, Burkhard
    Koch, Michael
    Giani, Guido
    Glaeske, Gerd
    Icks, Andrea
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (05) : 1634 - 1640